All-Spectrum Transradial Approach: Safer than Femoral

Original Title: Radial vs femoral access for coronary interventions across the entire spectrum of patients with coronary artery disease: a meta-analysis of randomized trials.

Reference: Ferrante G et al. J Am Coll Cardiol Intv. 2016; Epub ahead of print.

 

acceso_radial_finalRegardless the type of coronary syndrome, the transradial approach results in lower mortality and complications compared to the femoral.

Some studies (especially on chronic and stable patients) have seen contradicting results as regards the advantages of the transradial approach over the femoral, which is why this meta-analyzis of 24 studies was carried out, involving over 22,843 patients with PCI in the context of ACS

  • without ST elevation
  • with ST elevation
  • in stable patients

The transradial approach showed lower risk of all cause death (OR 0.71, CI 95% 0.58 to 0.87) and lower risk of combined cardiovascular events (OR 0.84; CI 95% 0.75 to 0.94) in the general population.

The transradial approach was also associated to lower major bleeding rate (OR 0.53; CI 95% 0.42 to 0.65) and lower major vascular complications rate (OR 0.23; CI 95% 0.16 to 0.34).

Other important data resulting from this work is that MI and stroke rates resulted similar for both vascular access sites.

When analyzing outcomes according to clinical presentation, stable patients are those who benefit most from reduced major bleeding. In the group of ACS patients, ST elevation MI patients saw the greatest benefit with transradial approach.

Lastly, the experienced centers obtained the highest benefits vs. femoral approach.

 

Conclusion

The transradial approach reduces mortality and combined events, and improves safety because of reduced bleeding and vascular complications, compared to the femoral access.

 

Editorial Comment

The benefit of the transradial approach seems out of question; however, a great randomized study would be useful to understand the mechanisms behind this advantage. Reduced major bleeding seems to be the main reason behind mortality decrease, though it may not be enough: there may be other, hidden mechanisms involved.

 

We value your opinion. You are more than welcome to leave your comments, thoughts, questions or any ideas here below.

More articles by this author

Drugs for the Treatment of No-Reflow During PCI

The no-reflow phenomenon is one of the most frustrating complications of primary angioplasty (pPCI), reflecting persistent microvascular damage that, in the mid- to long-term,...

Rotational atherectomy and its technical secrets: use of floppy or ES guidewire

Rotational atherectomy (RA) remains a very useful tool in the management of severe coronary calcification. However, many of its technical aspects rely more on...

CRT 2026 | CUT-DRESS Trial: Lesion Preparation with Cutting Balloon

In-stent restenosis (ISR) continues to represent a relevant clinical challenge in contemporary coronary angioplasty practice. Despite advances in drug-eluting stents, neointimal hyperplasia and suboptimal...

CRT 2026 | Clopidogrel vs Aspirin as Long-Term Monotherapy After Coronary Angioplasty

The use of aspirin as chronic antiplatelet therapy after percutaneous coronary intervention (PCI) has historically been the standard recommended by international guidelines. However, recent...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related Articles

SOLACI Sessionsspot_img

Recent Articles

Drugs for the Treatment of No-Reflow During PCI

The no-reflow phenomenon is one of the most frustrating complications of primary angioplasty (pPCI), reflecting persistent microvascular damage that, in the mid- to long-term,...

Coronary revascularization before TAVI: prior PCI or conservative management?

The coexistence of coronary artery disease (CAD) in patients with severe aortic stenosis undergoing TAVI is common, with a reported prevalence ranging from 30%...

Rotational atherectomy and its technical secrets: use of floppy or ES guidewire

Rotational atherectomy (RA) remains a very useful tool in the management of severe coronary calcification. However, many of its technical aspects rely more on...